TrialJournal of hepatology2019

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY).

Eleanor Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.